The shareholders of SHS Gesellschaft für Beteiligungsmanagement mbH have appointed Manfred Ulmer-Weber as an additional managing director as of 15 July 2022. SHS is a private equity investor that makes investments in innovative companies in the healthcare, life science and medical technology sectors. The focus of the investments is on expansion financing, shareholder changes and succession situations. The shareholders are Sascha Alilovic, Hubertus Leonhardt, Dr Bernhard Schirmers and Uwe Steinbacher.
Manfred Ulmer-Weber, born in 1985, studied international business administration at the Eberhard Karls University in Tübingen and at the École de Management in Strasbourg. He started his career at SHS during his studies as an intern for the company. At the end of his internship, he stayed on as a student trainee and, based on his outstanding performance and flair for the industry, was offered a position as SHS Investment Manager in 2010. This was followed by his appointment as Senior Investment Manager in 2012 and Partner in 2019.
Manfred holds board and shareholder positions for SHS Funds, for example at the fast-growing portfolio companies Develco Pharma Schweiz AG, TRI Dental Implants Int. AG and Blazejewski MEDI-TECH GmbH.
"We are also aiming for further investments in the healthcare sector in the coming quarters," Ulmer-Weber continues. "With our sixth fund generation, we offer equity solutions for fast-growing companies and succession situations as a specialised sector investor.”
"We are very pleased to appoint our long-standing colleague and partner to the Executive Board," elaborates Managing Partner Hubertus Leonhardt. "Manfred will play a significant role in implementing the investment strategy of our new SHS VI fund generation."
SHS has a four-member management team, consisting of Ulmer-Weber, Sascha Alilovic, Hubertus Leonhardt and Uwe Steinbacher. Ulmer-Weber succeeds the retired Managing Partner and Founder Dr Bernhard Schirmers, who is still working as a transitional Founding Partner due to his retirement.
SHS Capital is a private equity provider founded in 1993 that invests in healthcare companies in Europe. The focus of the investments is on expansion financing, shareholder changes and succession situations. "Building European Healthcare Champions" is the investment philosophy according to which SHS finances and develops portfolio companies. The Tübingen-based investor takes both minority and majority stakes. The national and international investors in SHS funds include pension funds, funds of funds, foundations, family offices, strategic investors, entrepreneurs and the SHS management team. The equity investment of the AIFM-registered company is up to EUR 50 million. Volumes in excess of this can be realised with a network of co-investors. In its investment decisions, SHS attaches great importance to the consideration of ESG aspects and has therefore committed itself to the guidelines of the UN PRI. SHS is currently investing more than € 200 million from its sixth fund, which was launched in 2022.
More information at: http://www.shs-capital.eu
Are you interested in receiving regular updates about SHS? Subscribe to our Newsletter and follow us on LinkedIn
SHS Gesellschaft für Beteiligungsmanagement mbH
Bismarckstraße 12
72072 Tuebingen
Telefon: +49 (7071) 9169-0
Telefax: +49 (7071) 9169-190
http://www.shs-capital.eu/
PR & Marketing
E-Mail: sas@shs-capital.eu
